SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

XRP (XRP) is a cryptocurrency . XRP has a current supply of 99,985,583,260 with 63,516,606,953 in circulation. The last known price of XRP is 1.0099454 USD and is down -2.36 over the last 24 hours. It is currently trading on 1896 active market(s) with $2,532,309,467.05 traded over the last 24 hours. More information can be found at https://xrpl.org/.

Ripple

XRPs sharp decline alongside a broader crypto selloff has put a key psychological support level under pressure, prompting debate over whether the downturn will deepen or create a buying opportunity. Traders point to Bitcoin weakness, liquidation pressure and inflation-related rate concerns, while long-term holders continue to accumulate and others warn of further losses.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Summits FDA decision on ivonescimab for EGFR-mutated lung cancer is the dominant catalyst, with traders treating the PDUFA as a binary event. Debate centers on whether strong progression-free-survival results and a favorable overall-survival trend can offset the missed statistical-significance threshold for overall survival; bulls point to the drugs broader potential and AstraZenecas backing, while bears fear a rejection or delay.

Algorand (ALGO) is a cryptocurrency launched in 2019. Algorand has a current supply of 10,000,000,000 with 9,079,719,016.041028 in circulation. The last known price of Algorand is 0.08513994 USD and is down -2.94 over the last 24 hours. It is currently trading on 586 active market(s) with $61,102,468.95 traded over the last 24 hours. More information can be found at http://algorand.foundation.

Algorand

ALGOs persistent price weakness and difficulty holding support are driving bearish calls for further downside, while bulls frame the selloff as an accumulation opportunity. The debate also reflects broader crypto-market weakness, with some traders citing Bitcoins direction and others pointing to Algorands technology and tokenization potential.

AGNC Investment Corp. engages in the operation of a real estate investment trust. The firm invests in residential mortgage pass-through securities and collateralized mortgage obligations for which the principal and interest payments are guaranteed by the United States government-sponsored enterprise or by the United States government agency. It also invests in other types of mortgage and mortgage-related securities, such as credit risk transfer securities and non-Agency residential and commercial mortgage-backed securities, where repayment of principal and interest is not guaranteed by the United States government-sponsored enterprise or by the United States Government agency, and other assets related to the housing, mortgage, or real estate markets. The company was founded on January 7, 2008 and is headquartered in Bethesda, MD.

AGNC Investment Corp

AGNCs Q3 report showed a sharp decline in tangible book value and a negative economic return, with income only narrowly covering its monthly dividend, adding to pressure from rising Treasury yields and mortgage spreads. Traders are debating dividend-cut and further-downside risks against the appeal of buying the selloff for its high monthly yield.

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Johnson & Johnson

Johnson & Johnsons Q3 report drew attention as sluggish MedTech growth and a litigation-related charge overshadowed stronger pharmaceutical sales and a raised full-year outlook, prompting a sharp selloff. Traders are split between dip-buyers who see the reaction as overdone and skeptics focused on MedTech weakness and litigation risk; separate talk of a possible Sellas acquisition remains speculation.

Bitcoin (BTC) is a cryptocurrency launched in 2010. Users are able to generate BTC through the process of mining. Bitcoin has a current supply of 20,111,631. The last known price of Bitcoin is 68,229.80907922 USD and is down -4.02 over the last 24 hours. It is currently trading on 12780 active market(s) with $42,739,134,877.94 traded over the last 24 hours. More information can be found at https://bitcoin.org/.

Bitcoin

Bitcoins sharp selloff and loss of key support levels dominate the discussion. Traders are split between expecting further declines and viewing extreme fear and oversold conditions as a buying opportunity; some cite higher-rate concerns and ETF outflows as headwinds.

Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. The company was founded by Stanley T. Crooke, David J. Ecker, Christopher K. Mirabelli, and Brett P. Monia on January 10, 1989 and is headquartered in Carlsbad, CA.

Ionis Pharmaceuticals Inc

Ionis earnings-driven selloff is dominating discussion after it cut TRYNGOLZAs 2026 sales outlook roughly in half amid a slower-than-expected launch, despite a revenue beat and reaffirmed total revenue guidance. Traders are split between viewing the weaker launch execution as a reason for continued pressure and seeing the sharp drop as overdone, with some also noting insider purchases.

Fiserv, Inc. engages in the provision of financial services technology. It operates through the Merchant and Financial segments. The Merchant segment offers commerce-enabling products and services including merchant acquiring and digital commerce and mobile payment services, and security and fraud protection, stored-value, and pay-by-bank solutions to companies of all sizes. The Financial segment provides products and services such as processing of customer loan and deposit accounts, digital payments, and card transactions to financial institutions and corporate and public sector clients. The company was founded by Leslie M. Muma and George D. Dalton on July 31, 1984 and is headquartered in Milwaukee, WI.

Fiserv, Inc.

Fiservs rebound is being tied mainly to its post-earnings results, reaffirmed outlook, larger cost-savings target, and planned share repurchases, which have revived turnaround hopes after a steep decline. Traders remain divided between seeing sustained recovery and momentum, including possible short covering, and viewing the rally as fragile given lingering concerns about the business outlook.

Newsmax Inc. is a holding company, which engages in television broadcasting and multi-platform content publishing that produces original news and editorial content for consumers through various media outlets, including TV new channels, digital and print publications. It operates through the Broadcasting and Digital Segments. The Broadcasting segment produces and licenses news, business news and lifestyle content for distribution through both MVPDs and free OTT streaming platforms. The Digital segment is composed of Newsmax.com and affiliated websites. The company was founded by Christopher Ruddy in 1998 and is headquartered in Boca Raton, FL.

Newsmax Inc. - Ordinary Shares - Class B

Newsmax Inc

Newsmaxs better-than-expected Q3 results, including stronger revenue growth and a return to profitability, are driving attention. Bulls are celebrating the results and speculating about further momentum or a short squeeze, while some caution that a one-time payment boosted reported revenue and question the durability of underlying growth.

Alaska Air Group, Inc. is a holding company, which engages in the provision of air transportation services. It operates through the following segments: Alaska Airlines, Hawaiian Airlines, and Regional. The Alaska Airlines segment includes scheduled air transportation on Alaska's Boeing and Airbus jet aircraft for passengers and cargo. The Hawaiian Airlines segment refers to scheduled air transportation on Hawaiian's Boeing and Airbus aircraft for passengers and cargo. The Regional segment consists of Horizon's and other third-party carriers’ scheduled air transportation on E175 aircraft for passengers under CPAs. The company was founded in 1985 and is headquartered in Seattle, WA.

Alaska Air Group Inc.

The FAAs nationwide ground stop disrupted some Alaska Airlines flights, prompting concern about cancellations and operational costs. Traders criticized the response and speculated about its cause, while others viewed the reported lifting of the orders as a relief for airlines.

statis crypto Watchlist

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

#Ampio has agreed to a $3M settlement with $AMPE investors to resolve claims it misrepresented the effectiveness of Ampion for treating inflammatory conditions. 
 
If you bought $AMPE between December 29, 2020, and October 31, 2022, you can file a claim for payment here: https://11th.com/cases/ampio-shareholder-settlement

Ampio (AMPE) agreed to settle $3M with investors to end claims over misrepresenting the efficacy of Ampion in treating individuals with inflammatory conditio...

11th.com

Ampio (AMPE) $3M Shareholder Settlement

StockTwits Web

Ampio Pharmaceuticals Inc

 investors to resolve claims it misrepresented the effectiveness of Ampion for treating inflammatory conditions. 
 
If you bought 

 between December 29, 2020, and October 31, 2022, you can file a claim for payment here: 